This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Outcomes assessed in the review
The outcomes assessed were: the probability of CR-BSI when povidone-iodine solution is used; the risk ratio of CR-BSI for chlorhexidine gluconate solution; the probability of catheter colonisation when povidone-iodine solution is used; the risk ratio of catheter colonisation for chlorhexidine gluconate solution; the probability of death attributable to CR-BSI; and the probability of local infection if colonisation occurs.
All probabilities were calculated separately for central and peripheral catheter models.
Study designs and other criteria for inclusion in the review
The probabilities of CR-BSI and catheter colonisation with povidone iodine were derived from randomised controlled trials.
Sources searched to identify primary studies
Not reported.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Approximately 16 primary studies, of which 8 were randomised controlled trials, and one was a meta-analysis, were included in the review.
Methods of combining primary studies
The probabilities of CR-BSI and catheter colonisation with povidone iodine were derived by pooling data from randomised controlled trials comparing chlorhexidine gluconate with povidone-iodine solutions for insertion site care.
The probability of CR-BSI and catheter colonisation with chlorhexidine gluconate was determined by multiplying the probability of CR-BSI when povidone iodine was used by the summary risk ratio of CR-BSI when chlorhexidine gluconate was used. This calculation was based on the results of a published meta-analysis.
Investigation of differences between primary studies
The authors reported that different types of chlorhexidine gluconate solution were used in the individual trials from which the measure of effectiveness was derived. The formulations included 0.5% to 1% chlorhexidine gluconate alcoholic solution and 0.5% or 2% chlorhexidine gluconate aqueous solution. In a meta-analysis conducted by the authors, a sub-set analysis of aqueous and non-aqueous solutions showed similar effect sizes, but only the sub-set analysis of the five studies in which alcoholic solution was used produced a statistically significant reduction in CR-BSI. The authors concluded that the failure of chlorhexidine gluconate to achieve a significant difference, compared with
The cost data were treated as point estimates (i.e. the data were deterministic).
Indirect Costs
The indirect costs were not included in the analysis.
Currency

US dollars ($).
Sensitivity analysis
To assess the overall uncertainty associated with the results, the authors used a Monte Carlo simulation to conduct a multivariate sensitivity analysis. The distributions of the parameters were fitted so that the means were similar to the base-case, and so that the 95% central ranges corresponded with the ranges derived from the literature. The decision analysis model was simulated 10,000 times. The authors also conducted a series of one-way sensitivity analyses to evaluate the effect of varying individual parameters on the outcomes. They also estimated the incremental cost of chlorhexidine gluconate over povidone iodine under a variety of clinical situations, as different packages and amounts of povidone-iodine solution are used for catheter site care, and alcohol solution is sometimes applied before the catheter site is disinfected with povidone iodine.
Estimated benefits used in the economic analysis
The use of chlorhexidine gluconate rather than povidone iodine for central line catheter site care led to an absolute decrease in the incidence of CR-BSI of 16 cases per 1,000 catheters (from 31 to 15 cases per 1,000 catheters; numberneeded-to-treat, NNT of 64 patients). It also led to a decrease in the incidence of death attributable to CR-BSI of 2 cases per 1,000 catheters (from 4 to 2 cases per 1,000 catheters; NNT 435 patients).
The use of chlorhexidine gluconate rather than povidone iodine for peripheral line catheter site care led to an absolute decrease in the incidence of CR-BSI of 5 cases per 1,000 catheters (from 9 to 4 cases per 1,000 catheters; NNT 213 patients). It also led to a decrease in the incidence of death attributable to CR-BSI of 0.05 cases per 1,000 catheters (from 0.10 to 0.05 cases per 1,000 catheters; NNT 21,277 patients).
Cost results
Compared with the use of povidone iodine in central line catheter site care, chlorhexidine gluconate resulted in expected cost-savings of $113 for each catheter used (cost decreased from $224 to $111 for each catheter used).
Compared with the use of povidone iodine in peripheral line catheter site care, chlorhexidine gluconate resulted in expected cost-savings of $8 for each catheter used (cost decreased from $16 to $8 for each catheter used).
Synthesis of costs and benefits
As chlorhexidine gluconate was dominant over povidone iodine (i.e. it was more effective and less expensive), a synthesis of the costs and benefits was not relevant. In the Monte Carlo analysis, the use of chlorhexidine gluconate produced cost-savings in over 99% of the simulations. The results were found to be robust in one-way sensitivity analyses.
Authors' conclusions
The use of chlorhexidine gluconate for patients requiring short-term vascular catheterisation, either with central or peripheral catheters, would reduce the incidence of vascular catheter-related infection. It would also decrease the health care costs.
CRD COMMENTARY -Selection of comparators
A justification was given for using povidone iodine as the comparator. It represented the current standard solution for vascular catheter insertion site care in the authors' setting. You should decide if this is a widely used health technology in your own setting.
Validity of estimate of measure of effectiveness
The authors did not report that a systematic review of the literature was undertaken to identify all relevant research and minimise biases. They also did not report the sources searched for relevant research. Despite this, the review and synthesis of the literature were based on up-to-date studies, the oldest being published in 1991, with a majority of studies being randomised controlled trials. The effectiveness estimates were combined using a meta-analysis and, where appropriate, the authors considered the impact of differences between the primary studies on the effectiveness estimates. In addition, uncertainty in the model was evaluated using a probabilistic sensitivity analysis based on all of the outcomes derived from the literature.
Validity of estimate of measure of benefit
The estimation of benefits was modelled. The decision analytic model used to derive these estimates appears to have been appropriate.
Validity of estimate of costs
All the categories of cost relevant to the perspective adopted were included in the analysis. As such, all the relevant costs appear to have been included. The costs and the quantities were reported separately, which will enhance the generalisability of the authors' results. Resource use and costs were derived from a number of published sources. Uncertainty in these parameters was appropriately evaluated in a probabilistic sensitivity analysis. Discounting was unnecessary since all the costs were incurred during a short time. The price year was reported, which will aid any inflation exercises.
Other issues
The authors made appropriate comparisons of their findings with those from other studies that found that the incidence of CR-BSI was significantly lower among patients whose catheter sites were disinfected with chlorhexidine gluconate rather than povidone iodine. However, it does appear that no study has quantified the cost-effectiveness of chlorhexidine gluconate. The issue of generalisability to other settings was appropriately addressed in the sensitivity analysis. The authors do not appear to have presented their results selectively and their conclusions reflected the scope of the analysis.
